| Lastest Insider Transactions Of iTeos Therapeutics, Inc. ( ITOS ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| ITOS | iTeos Therapeutics, Inc. | MPM BioVentures 2014, L.P. | 10% Owner | 2021-09-07 | Sell | 42,566 | 29.03 | 1,235,644 | 2021-09-08 19:13:11 |
| ITOS | iTeos Therapeutics, Inc. | MPM BIOVENTURES 2018, L.P. | 10% Owner | 2021-09-07 | Sell | 42,566 | 29.03 | 1,235,644 | 2021-09-08 19:12:06 |
| ITOS | iTeos Therapeutics, Inc. | Detheux Michel | Chief Executive Officer | 2021-09-01 | Sell | 20,252 | 28.66 | 580,518 | 2021-09-03 20:00:34 |
| ITOS | iTeos Therapeutics, Inc. | Detheux Michel | Chief Executive Officer | 2021-08-23 | Sell | 8,585 | 28.06 | 240,890 | 2021-08-25 20:03:40 |
| ITOS | iTeos Therapeutics, Inc. | Detheux Michel | Chief Executive Officer | 2021-06-14 | Sell | 29,000 | 28.50 | 826,534 | 2021-06-16 18:48:47 |
| ITOS | iTeos Therapeutics, Inc. | McGrath Yvonne | VP, Research and Development | 2021-06-08 | Sell | 7,927 | 20.00 | 158,540 | 2021-06-10 17:35:12 |
| ITOS | iTeos Therapeutics, Inc. | McGrath Yvonne | VP, Research and Development | 2021-06-08 | Option Exercise | 7,927 | 4.23 | 33,531 | 2021-06-10 17:35:12 |
| ITOS | iTeos Therapeutics, Inc. | McGrath Yvonne | VP, Research and Development | 2021-05-24 | Sell | 7,927 | 21.92 | 173,796 | 2021-06-03 16:19:01 |
| ITOS | iTeos Therapeutics, Inc. | McGrath Yvonne | VP, Research and Development | 2021-05-24 | Option Exercise | 7,927 | 4.23 | 33,531 | 2021-06-03 16:19:01 |
| ITOS | iTeos Therapeutics, Inc. | McGrath Yvonne | VP, Research and Development | 2021-06-01 | Sell | 7,927 | 20.17 | 159,903 | 2021-06-03 16:17:55 |
| ITOS | iTeos Therapeutics, Inc. | McGrath Yvonne | VP, Research and Development | 2021-06-01 | Option Exercise | 7,927 | 4.23 | 33,531 | 2021-06-03 16:17:55 |
| ITOS | iTeos Therapeutics, Inc. | McGrath Yvonne | VP, Research and Development | 2021-05-24 | Sell | 7,927 | 21.92 | 173,796 | 2021-05-26 16:09:22 |
| ITOS | iTeos Therapeutics, Inc. | McGrath Yvonne | VP, Research and Development | 2021-05-24 | Option Exercise | 7,927 | 4.23 | 33,531 | 2021-05-26 16:09:22 |
| ITOS | iTeos Therapeutics, Inc. | MPM BioVentures 2014, L.P. | 10% Owner | 2021-04-09 | Sell | 119 | 29.99 | 3,569 | 2021-04-13 16:16:42 |
| ITOS | iTeos Therapeutics, Inc. | MPM BIOVENTURES 2018, L.P. | 10% Owner | 2021-04-09 | Sell | 119 | 29.99 | 3,569 | 2021-04-13 16:15:51 |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | 2021-04-09 | Sell | 200 | 29.99 | 5,998 | 2021-04-13 16:15:02 |
| ITOS | iTeos Therapeutics, Inc. | GADICKE ANSBERT | 10% Owner | 2021-04-07 | Sell | 41,982 | 30.99 | 1,300,850 | 2021-04-09 16:47:12 |
| ITOS | iTeos Therapeutics, Inc. | MPM BioVentures 2014, L.P. | 10% Owner | 2021-04-07 | Sell | 25,087 | 30.99 | 777,343 | 2021-04-09 16:10:19 |
| ITOS | iTeos Therapeutics, Inc. | MPM BIOVENTURES 2018, L.P. | 10% Owner | 2021-04-07 | Sell | 25,087 | 30.99 | 777,343 | 2021-04-09 16:09:19 |
